Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Péter Bacsur, Tamás Resál, Patrícia Sarlós, Ákos Iliás, Liza Dalma Sümegi, Diána Kata, Anett Dávid, Bernadett Farkas, Emese Ivány, Anita Bálint, Zsófia Bősze, Anna Fábián, Renáta Bor, Zoltán Szepes, Waqqas Afif, Talat Bessissow, Klaudia Farkas, Péter L. Lakatos, Tamás Molnár

Journal title: Therapeutic Advances in Gastroenterology

Journal number: 17

Journal publisher: SAGE Publications Ltd.

Published year: 2024

DOI identifier: 10.1177/17562848241290636

ISSN: 1756-2848